Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurence Vergne

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Antiviral Therapy|September 13, 2006
HIV-1 drug-resistance mutations among newly diagnosed patients before scaling-up programmes in Burkina Faso and CameroonLaurence Vergne, Serge Diagbouga, Charles Kouanfack, et al.
Antiviral Therapy|May 29, 2009
Evaluation of transmitted HIV drug resistance among recently-infected antenatal clinic attendees in four Central African countriesAvelin F Aghokeng, Laurence Vergne, Eitel Mpoudi-Ngole, et al.
AIDS (London, England)|November 23, 2006
Impact of suppressive herpes therapy on genital HIV-1 RNA among women taking antiretroviral therapy: a randomized controlled trialAbdoulaye Ouedraogo, Nicolas Nagot, Laurence Vergne, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 21, 2004
Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adultsChristian Laurent, Ndeye Fatou Ngom Gueye, Cheikh Tidiane Ndour, et al.
AIDS (London, England)|October 21, 2003
Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapyLaurence Vergne, Coumba Touré Kane, Christian Laurent, et al.
AIDS (London, England)|July 20, 2002
The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up studyChristian Laurent, Ndella Diakhaté, Ndeye Fatou Ngom Gueye, et al.
The New England Journal of Medicine|February 23, 2007
Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virusNicolas Nagot, Abdoulaye Ouédraogo, Vincent Foulongne, et al.
AIDS Research and Human Retroviruses|November 6, 2009
Low prevalence of HIV type 1 drug resistance mutations in untreated, recently infected patients from Burkina Faso, Côte d'Ivoire, Senegal, Thailand, and Vietnam: the ANRS 12134 studyAhidjo Ayouba, Truong T X Lien, Janin Nouhin, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Antiviral Therapy|September 13, 2006
HIV-1 drug-resistance mutations among newly diagnosed patients before scaling-up programmes in Burkina Faso and CameroonLaurence Vergne, Serge Diagbouga, Charles Kouanfack, et al.
Antiviral Therapy|May 29, 2009
Evaluation of transmitted HIV drug resistance among recently-infected antenatal clinic attendees in four Central African countriesAvelin F Aghokeng, Laurence Vergne, Eitel Mpoudi-Ngole, et al.
AIDS (London, England)|November 23, 2006
Impact of suppressive herpes therapy on genital HIV-1 RNA among women taking antiretroviral therapy: a randomized controlled trialAbdoulaye Ouedraogo, Nicolas Nagot, Laurence Vergne, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 21, 2004
Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adultsChristian Laurent, Ndeye Fatou Ngom Gueye, Cheikh Tidiane Ndour, et al.
AIDS (London, England)|October 21, 2003
Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapyLaurence Vergne, Coumba Touré Kane, Christian Laurent, et al.
AIDS (London, England)|July 20, 2002
The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up studyChristian Laurent, Ndella Diakhaté, Ndeye Fatou Ngom Gueye, et al.
The New England Journal of Medicine|February 23, 2007
Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virusNicolas Nagot, Abdoulaye Ouédraogo, Vincent Foulongne, et al.
AIDS Research and Human Retroviruses|November 6, 2009
Low prevalence of HIV type 1 drug resistance mutations in untreated, recently infected patients from Burkina Faso, Côte d'Ivoire, Senegal, Thailand, and Vietnam: the ANRS 12134 studyAhidjo Ayouba, Truong T X Lien, Janin Nouhin, et al.
Pageof 2